Priya Sachdeva
Stock Analyst at UBS
(3.57)
# 2,255
Out of 4,673 analysts
14
Total ratings
90%
Success rate
25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Priya Sachdeva
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRC AtriCure | Rated: Buy | $50 | $48.98 | +2.08% | 1 | Jul 28, 2026 | |
| MDT Medtronic | Rated: Hold | $90 → $85 | $93.35 | -8.94% | 2 | Jun 4, 2026 | |
| PEN Penumbra | Downgraded: Hold | $335 → $374 | $325.18 | +15.01% | 7 | Jan 20, 2026 | |
| NPCE NeuroPace | Maintained: Buy | $18 → $22 | $14.03 | +56.81% | 4 | Dec 16, 2025 |
AtriCure
Jul 28, 2026
Rated: Buy
Price Target: $50
Current: $48.98
Upside: +2.08%
Medtronic
Jun 4, 2026
Rated: Hold
Price Target: $90 → $85
Current: $93.35
Upside: -8.94%
Penumbra
Jan 20, 2026
Downgraded: Hold
Price Target: $335 → $374
Current: $325.18
Upside: +15.01%
NeuroPace
Dec 16, 2025
Maintained: Buy
Price Target: $18 → $22
Current: $14.03
Upside: +56.81%